These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 29524532)

  • 21. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
    Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
    BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
    Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
    BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.
    Wong KM; Yeh ML; Chuang SC; Wang LY; Lin ZY; Chen SC; Tsai JF; Wang SN; Kuo KK; Dai CY; Yu ML; Lee KT; Chuang WL
    Indian J Gastroenterol; 2013 Jul; 32(4):253-7. PubMed ID: 22932964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry.
    Lee SH; Jin YJ; Lee JW
    Medicine (Baltimore); 2017 Nov; 96(44):e8486. PubMed ID: 29095307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
    Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.
    Chen W; Lin X; Wu Z; Pan W; Ke Q; Chen Y
    Hepatol Int; 2024 Jun; 18(3):998-1010. PubMed ID: 38480604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
    Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study.
    Song KD; Lim HK; Rhim H; Lee MW; Kim YS; Lee WJ; Paik YH; Gwak GY; Kim JM; Kwon CH; Joh JW
    Radiology; 2015 May; 275(2):599-608. PubMed ID: 25559235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation and/or Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
    Orimo T; Kamiyama T; Yokoo H; Wakayama K; Shimada S; Einama T; Kamachi H; Taketomi A
    Dig Surg; 2018; 35(5):427-434. PubMed ID: 28903105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery.
    Chen S; Peng Z; Xiao H; Lin M; Chen Z; Jiang C; Hu W; Xie X; Liu L; Peng B; Kuang M
    Int J Hyperthermia; 2018 Nov; 34(7):1029-1037. PubMed ID: 28974113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.